In these 13 cases of P-SCAD, clinical presentation commonly included acute myocardial infarction and cardiogenic shock. Multivessel dissections and involvement of the left coronary artery and left main coronary artery were highly prevalent. Clinicians must be aware of angiographic appearances of P-SCAD for prompt diagnosis and management in these high-risk patients.
Contemporary Bare Metal Stents Implantation: Comparison of Stainless Steel versus Cobalt Chromium Coronary Stents Introduction: Higher strut thickness of coronary bare metal stents is associated with restenosis risk after bare metal stent implantation. New bare metal stents with thin struts have been developed, but there have been few studies comparing these new devices. Methods: from February 2004 until January 2007, 475 consecutive patients underwent percutaneous coronary intervention treating "de novo" coronary lesions exclusively using BMS. One hundred and eleven patients with stainless steel stent (Liberté ®group I) and 364 with cobalt chromium stent (Driver ®group II). Bypass venous graft, cardiogenic shock and restenosis were excluded. Patient progress was evaluated during their hospital stay and an average 18-month outpatient follow-up. Results: Angiographic success in almost all cases, with reduced in-hospital cardiac complications. Over an average 18-month period we found a low incidence of major adverse cardiac events (10.1 vs 7.3%; p=0.2) and a reduction in target vessel revascularization procedures (8.6 vs 6.9%; p=0.3). Conclusion: Implantation of new generation BMS with thinner-struts to treat "de novo" coronary lesions, in a select population, reduces target vessel revascularization to below 10%, with both devices achieving similar results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.